Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Supernus Pharm (SUPN)

39.4 0.95 (2.47%)

02-23 16:00

Open:

38.55

Pre. Close:

38.45

High:

39.7

Low:

38.15

Volume:

271,413

Market Cap:

2020M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

39.76 - 39.92

39.92 - 40.085

Low:

37.765 - 37.928

37.928 - 38.095

Close:

39.127 - 39.416

39.416 - 39.714

Technical analysis  (as of: 2018-02-23 4:42:30 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 50.69     One year: 56.82

Support:

Support1: 34.90    Support2: 29.04

Resistance:

Resistance1: 43.40    Resistance2: 48.65

Pivot:

38.28

Moving Averages:

MA(5): 38.31     MA(20): 38.83

MA(100): 40.01     MA(250): 38.62

MACD:

MACD(12,26): -0.71     Signal(12,26,9): -0.78

%K %D:

%K(14,3): 59.99     %D(3): 50.91

RSI:

RSI(14): 49.84

52-Week:

High: 50.05  Low: 24.92  Change(%): 47.8

Average Vol(K):

3-Month: 58494  10-Days 41713

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SUPN has closed below upper band by 13.3%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to SUPN's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 19 Feb 2018 22:30:00 GMT
Should You Expect Supernus Pharmaceuticals Inc (NASDAQ:SUPN) To Continue ...

Fri, 23 Feb 2018 03:11:15 GMT
Ranger Investment Management Lp Decreased Supernus Pharmaceuticals Inc ...

Fri, 23 Feb 2018 07:41:15 GMT
Supernus Pharmaceuticals Inc (SUPN) Expected to Announce Quarterly Sales of ...

Wed, 21 Feb 2018 00:45:00 GMT
Supernus Pharmaceuticals,Inc. (NASDAQ:SUPN) Files An 8-K Departure of ...

Thu, 22 Feb 2018 11:26:15 GMT
Quotidian Technical Highlights on Selected Generic Drugs Stocks -- Allergan ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

51.26

Shares Float (M)

50.38

% Held by Insiders

% Held by Institutions

88.50

Shares Short (K)

4076

Shares Short Prior Month (K)

3910

Stock Financials

EPS

1.060

EPS Est. Current Year

1.040

EPS Est. Next Year

1.660

EPS Est. Next Quarter

0.260

Forward EPS

1.560

Book Value (p.s.)

7.810

PEG Ratio

1.38

Profit Margin

20.40

Operating Margin

29.51

Return on Assets (ttm)

17.0

Return on Equity (ttm)

26.8

Qtrly Rev. Growth

41.5

Gross Profit (p.s.)

5.098

Sales Per Share

EBITDA (p.s.)

1.768

Qtrly Earnings Growth

-74.20

Operating Cash Flow (M)

103.24

Levered Free Cash Flow (M)

77.68

atoplab.com

Valuation

P/E

37.17

P/E Growth Ratio

0.02

P/BV

5.04

P/S

368548192.00

P/CF

19.56

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.